Background No data from randomised controlled trials of metabolic surgery for diabetes are
available beyond 5 years of follow-up. We aimed to assess 10-year follow-up after surgery …

Aim To compare different types of metabolic surgery (MS) with medical therapy (MT) for the
treatment of type 2 diabetes (T2D). Materials and methods We conducted a network‐meta …

BACKGROUND Despite growing evidence that bariatric/metabolic surgery powerfully
improves type 2 diabetes (T2D), existing diabetes treatment algorithms do not include …

OBJECTIVE The overall aim of the Alliance of Randomized Trials of Medicine versus
Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) consortium is to assess the durability …

Since the 2007 Diabetes Surgery Summit in Rome, Italy, and the subsequent publishing of
the world's first guidelines for the surgical treatment of type 2 diabetes (T2D), much new …

Background Randomised controlled trials have shown that bariatric surgery is more effective
than conventional treatment for the short-term control of type-2 diabetes. However …

Several gastrointestinal (GI) operations that were designed to promote weight loss can
powerfully ameliorate type 2 diabetes mellitus (T2DM). Although T2DM is traditionally …

Bariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes
mellitus (T2DM) with body mass index (BMI)≧ 35 kg/m2. Mounting evidence also shows that …

Several bariatric operations originally designed to promote weight loss have been found to
powerfully treat type 2 diabetes, causing remission in most cases, through diverse …

Objective: To compare surgical versus medical treatment of type 2 diabetes mellitus (T2DM)
remission and comorbidities in patients with a body mass index (BMI) less than 35 kg/m 2 …